Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - TOTAL LIABILITIES
Total Liabilities ADAP - Adaptimmune Therapeutics plc
234 M
LAST VALUE
-2.65%
2 YEAR CAGR
32.23%
5 YEAR CAGR
15.99%
10 YEAR CAGR